Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small animals models for drug discovery.

James G Martin1, Mauro Novali

  • 1Meakins Christie Laboratories, McGill University, 3626 St. Urbain St., Montreal, Quebec, Canada. james.martin@mcgill.ca

Pulmonary Pharmacology & Therapeutics
|May 24, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.2K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.2K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Umbilical cord mesenchymal stromal cells for respiratory complications of COVID-19 infection (ProTrans): phase II randomized clinical trial.

Cytotherapy·2026
Same author

Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.

Tumori·2025
Same author

Leukotriene C4 Synthase Deficiency Causes Spontaneous Emphysema in Female Mice.

American journal of respiratory cell and molecular biology·2025
Same author

IL-33 Induces a Protective Response against Irritant-induced Airway Inflammation and Dysfunction.

American journal of respiratory cell and molecular biology·2025
Same author

Anti-ST2 antibody reduces airway hyperresponsiveness mediated by monocyte-derived macrophages during influenza A infection.

Mucosal immunology·2025
Same author

Pregnancy enhances antiviral immunity independent of type I IFN but dependent on IL-17-producing γδ<sup>+</sup> T cells in the nasal mucosa.

Science advances·2024
Same journal

Brain-derived neurotrophic factor (BDNF) signaling in respiratory disease: Mechanisms, neuroimmune crosstalk, and therapeutic implications.

Pulmonary pharmacology & therapeutics·2026
Same journal

PD05, a novel neutrophil elastase inhibitor, mitigates LPS-induced acute lung injury in a preclinical model.

Pulmonary pharmacology & therapeutics·2026
Same journal

The preclinical discovery and development of depemokimab for severe eosinophilic asthma.

Pulmonary pharmacology & therapeutics·2026
Same journal

TROP2 as a promising therapeutic target in lung cancer: Current clinical trial landscape and future directions.

Pulmonary pharmacology & therapeutics·2026
Same journal

Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment.

Pulmonary pharmacology & therapeutics·2026
Same journal

Evodiamine protects against lung ischemia-reperfusion injury by attenuating SYK-associated TLR4/NLRP3 inflammasome activation and ferroptosis-related injury signatures.

Pulmonary pharmacology & therapeutics·2026
See all related articles

Animal models have advanced understanding of allergy and asthma immunology. However, translating these findings to human asthma remains challenging due to diverse disease phenotypes.

Area of Science:

  • Immunology
  • Allergy Research
  • Asthma Modeling

Background:

  • Extensive research in animal models over 20 years has clarified immunological mechanisms of allergy.
  • Complex cytokine and chemokine networks in allergic responses are increasingly understood.

Purpose of the Study:

  • To review the progress and challenges in utilizing animal models for asthma research.
  • To identify new directions for improving asthma modeling.

Main Methods:

  • Review of immunological studies on animal models of asthma.
  • Analysis of the translation gap between animal model findings and human asthma phenotypes.

Main Results:

  • Significant progress in understanding fundamental allergy immunology and cytokine networks.

Related Experiment Videos

  • Slow translation of findings to human asthma due to phenotypic variability.
  • Conclusions:

    • Animal models have provided valuable insights into asthma pathogenesis.
    • Future research should expand modeling to include viral infections, oxidant stress, and innate/adaptive immune interactions for better human asthma relevance.